• Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Recommendation of "Moderate Buy" by Analysts

    ソース: Buzz FX / 14 3 2025 02:56:16   America/New_York


    Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat March 14, 2025 Share Link copied to clipboard. Remove Ads Shares of Kymera Therapeutics, Inc.
    Read more...
シェアする